← All trials
NCT04887285
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 3, 2022
- Primary completion
- Aug 14, 2023
- Completion date
- Sep 14, 2023
- First posted
- May 14, 2021
- Last posted
- Sep 5, 2021
- Enrollment
- 126
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Johns Hopkins UniversityLead sponsor
- United States ArmyCollaborator
- United States ArmyStudy director
- United States NavyCollaborator
- United States NavyStudy director
- Harvard UniversityCollaborator
- Harvard UniversityStudy director
- Johns Hopkins UniversityOverall official - principal investigator
- Department of DefenseCollaborator
- The Geneva FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.